RXRX

NASDAQ · Biotechnology

Recursion Pharmaceuticals-A

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.22

+0.04 (+1.26%)

As of Aug 8, 10:03 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 57%

Hold 6 43%

Sell 0 0%

Price Target

Analyst Price Target +797.5% upside

Low Target $21.05

Average Target $28.90

High Target $39.88

Current Price $3.22

Current
$3.22

Target
$28.90

$21.05 $28.90 avg $39.88

Scenario Analysis

Bear Case

$21.05

553.7%

Low target

Base Case

$28.90

+797.5%

Avg target

Bull Case

$39.88

+1,138.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$7.18

-55.2% from high

52-Week Low

$2.77

+16.2% from low

50-Day SMA

$4.31

-25.3% vs SMA

200-Day SMA

$4.89

-34.2% vs SMA

RSI (14)

34.7

Neutral

Target vs 52W High

$28.90

+302.5% vs high

Next Earnings Report

Aug 11, 2026

until earnings

EPS Est: $-0.24

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%